DOI QR코드

DOI QR Code

Malignant lymphoma on parotid gland: a clinical case

  • Lee, Hyeong-Geun (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University) ;
  • Lee, Jae-Yeol (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University) ;
  • Song, Jae-Min (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University)
  • Received : 2016.08.02
  • Accepted : 2016.12.11
  • Published : 2017.04.30

Abstract

Non-Hodgkin's lymphoma on the parotid gland is a relatively rare occurrence among head and neck tumors. The mass of parotid gland lymphoma cannot be distinguished from other benign masses of the parotid gland; therefore, it is important to consider lymphoma in the differential diagnosis when examining parotid swellings and masses. Parotid gland lymphoma is most likely to be B-cell, non-Hodgkin's lymphoma of one of three types, which include follicular, marginal zone, and diffuse large B-cell, although other histologic patterns have been described. We present a review of a patient with diffuse large B-cell lymphoma (DLBCL) who presented to the Department of Oral and Maxillofacial Surgery of Pusan National University Hospital (Yangsan, Korea).

Keywords

References

  1. Huh J. Epidemiologic overview of malignant lymphoma. Korean J Hematol 2012;47:92-104. https://doi.org/10.5045/kjh.2012.47.2.92
  2. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011;117:5019-32. https://doi.org/10.1182/blood-2011-01-293050
  3. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Thiele J, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008:9-32.
  4. Wolvius EB, van der Valk P, van der Wal JE, van Diest PJ, Huijgens PC, van der Waal I, et al. Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Eur J Cancer B Oral Oncol 1994;30B:121-5.
  5. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin 1993;43:7-26. https://doi.org/10.3322/canjclin.43.1.7
  6. Iguchi H, Wada T, Matsushita N, Oishi M, Yamane H. Anatomic distribution of hematolymphoid malignancies in the head and neck: 7 years of experience with 122 patients in a single institution. Acta Otolaryngol 2012;132:1224-31. https://doi.org/10.3109/00016489.2012.694474
  7. Zapater E, Bagan JV, Carbonell F, Basterra J. Malignant lymphoma of the head and neck. Oral Dis 2010;16:119-28. https://doi.org/10.1111/j.1601-0825.2009.01586.x
  8. Mehle ME, Kraus DH, Wood BG, Tubbs R, Tucker HM, Lavertu P. Lymphoma of the parotid gland. Laryngoscope 1993;103:17-21. https://doi.org/10.1002/lary.1993.103.s60.17
  9. Loggins JP, Urquhart A. Preoperative distinction of parotid lymphomas. J Am Coll Surg 2004;199:58-61.
  10. Dispenza F, Cicero G, Mortellaro G, Marchese D, Kulamarva G, Dispenza C. Primary non-Hodgkins lymphoma of the parotid gland. Braz J Otorhinolaryngol 2011;77:639-44. https://doi.org/10.1590/S1808-86942011000500017
  11. Abbaszadeh-Bidokhty H, Mohtasham N, Pazouki M, Babakoohi S. Primary diffuse large B-cell lymphoma of the mandible: a case report. J Oral Maxillofac Surg Med Pathol 2014;26:98-100. https://doi.org/10.1016/j.ajoms.2012.08.014
  12. Eisenbud L, Sciubba J, Mir R, Sachs SA. Oral presentations in non-Hodgkin's lymphoma: a review of thirty-one cases. Part II. Fourteen cases arising in bone. Oral Surg Oral Med Oral Pathol 1984;57:272-80. https://doi.org/10.1016/0030-4220(84)90183-X
  13. Barnes L, Myers EN, Prokopakis EP. Primary malignant lymphoma of the parotid gland. Arch Otolaryngol Head Neck Surg 1998;124:573-7. https://doi.org/10.1001/archotol.124.5.573
  14. Shum JW, Emmerling M, Lubek JE, Ord RA. Parotid lymphoma: a review of clinical presentation and management. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:e1-5. https://doi.org/10.1016/j.oooo.2013.10.013
  15. Ekstrom Smedby K, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the Inter-Lymph Consortium. Blood 2008;111:4029-38. https://doi.org/10.1182/blood-2007-10-119974
  16. Feinstein AJ, Ciarleglio MM, Cong X, Otremba MD, Judson BL. Parotid gland lymphoma: prognostic analysis of 2140 patients. Laryngoscope 2013;123:1199-203. https://doi.org/10.1002/lary.23901
  17. Koyuncu M, Sesen T, Akan H, Ismailoglu AA, Tanyeri Y, Tekat A, et al. Comparison of computed tomography and magnetic resonance imaging in the diagnosis of parotid tumors. Otolaryngol Head Neck Surg 2003;129:726-32. https://doi.org/10.1016/j.otohns.2003.07.009
  18. Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet 2012;380:848-57. https://doi.org/10.1016/S0140-6736(12)60605-9
  19. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-42. https://doi.org/10.1056/NEJMoa011795
  20. Chernoff WG, Lampe HB, Cramer H, Banerjee D. The potential clinical impact of the fine needle aspiration/flow cytometric diagnosis of malignant lymphoma. J Otolaryngol 1992;21 Suppl 1:1-15.

Cited by

  1. Mucosa-associated lymphoid tissue lymphoma of the accessory parotid gland presenting as a simple cheek mass : A case report vol.98, pp.36, 2017, https://doi.org/10.1097/md.0000000000017042